UPDATE : Tuesday, August 14, 2018
상단여백
GC’s development of flu vaccine for seniors goes as planned
Green Cross said Thursday that it has received approval from the Ministry o...
by Lee Han-soo  |  2018-07-26 11:18
라인
[Exclusive] Invossa patent expired in 6 European countries
Kolon Life Science has lost its substance patent for Invossa-K, a cell gene...
by Nam Doo-hyun  |  2018-07-26 11:16
라인
Alteogen develops world’s 2nd human hyaluronidase technology
Alteogen, a Korean developer of bio-beta, said Wednesday that it has become...
by Lee Han-soo  |  2018-07-25 17:27
라인
Bukwang keeps taking subsidiaries public to expand business
Bukwang Pharmaceutical said it would get its wholly owned subsidiary Dyna S...
by Lee Han-soo  |  2018-07-25 17:23
라인
GC Labcell posts ₩13.2 billion in Q2 sales
GC Labcell said Tuesday that it recorded 13.2 billion won ($11.7 million) i...
by Lee Han-soo  |  2018-07-25 15:07
라인
Novo Nordisk’s Tresiba reiterates importance of RWD
With the advent of the Fourth Industrial Revolution, there is a change in t...
by Lee Han-soo  |  2018-07-25 14:22
라인
Which multinational drugmaker grew most rapidly in H1?
Daiichi Sankyo Korea achieved the most substantive sales growth among multi...
by Nam Doo-hyun  |  2018-07-25 11:52
라인
Pfizer Korea stops recruitment procedure
Pfizer Korea is stirring controversy, as the company abruptly canceled its ...
by Lee Han-soo  |  2018-07-24 17:01
라인
Antidiabetic drug Zemiglo up, cancer drug Supect down in H1 sales
Locally developed new drugs showed mixed performances in prescriptions in t...
by So Jae-hyeon  |  2018-07-24 11:11
라인
Stock declines, negative rumors haunt biotech industry
The local biotech industry is struggling with negative rumors on leading fi...
by So Jae-hyeon  |  2018-07-23 16:39
라인
Il-yang gets 1-month suspension on quadrivalent flu vaccine
The government has suspended Il-yang Pharmaceutical’s manufacturing of Tera...
by Lee Hye-seon  |  2018-07-20 14:58
라인
Latecomer Lixiana’s chase after Eliquis gets faster
Daiichi Sankyo’s Lixiana, a latecomer in the non-vitamin K antagonist oral ...
by So Jae-hyeon  |  2018-07-20 12:01
라인
Bifido wins patent for microbiome-based treatment in US
Bifido said it has become the first domestic company to win a patent for a ...
by So Jae-hyeon  |  2018-07-19 15:42
라인
Xofigo combinations raise fracture risk
Combinations using Bayer Korea’s prostate cancer treatment Xofigo Inj. (ing...
by Lee Hye-seon  |  2018-07-19 13:59
라인
Joint R&D program to test Keytruda combo in breast cancer patients
The Korea Drug Development Fund (KDDF) and MSD Korea have selected Genexine...
by Marian Chu  |  2018-07-18 17:53
라인
Kolon Life Science inks deal to sell Invossa to China
Kolon Life Science said Wednesday it has signed a deal to sell 230 billion ...
by So Jae-hyeon  |  2018-07-18 16:46
라인
L&K Biomed gets FDA nod for sacroiliac joint disease implant system
L&K Biomed has received the U.S. Food and Drug Administration’s approval We...
by Marian Chu  |  2018-07-18 16:26
라인
SK Bioscience to expand vaccine production facility
SK Bioscience is pursuing its growth strategy by expanding its vaccine prod...
by Marian Chu  |  2018-07-18 16:13
라인
ViroMed secures DNA production plant in US
ViroMed said Wednesday it acquired a DNA production facility in San Diego, ...
by Marian Chu  |  2018-07-18 15:02
라인
Dong-A ST’s Jublia dominates athlete’s foot drugs
The sales of Dong-A ST’s Jublia, a toenail fungal treatment, has grown rapi...
by So Jae-hyeon  |  2018-07-18 11:50
여백
여백
여백
Back to Top